ImmunityBio News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

11.12.24	What's Going On With ImmunityBio Shares Wednesday? (Benzinga)
11.12.24	ImmunityBio Prices 33.33 Mln Public Offering At $3.00 Per Share, Stock Down (RTTNews)
27.10.24	Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? (Benzinga)
23.10.24	800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio (Benzinga)
20.06.24	Why ImmunityBio Stock Is Trading Higher Thursday (Benzinga)
04.06.24	LadRx And ImmunityBio Agree To Terminate Aldoxorubicin License (RTTNews)
28.03.24	Biotech Stocks Facing FDA Decision In April 2024 (RTTNews)
24.08.23	IBRX FINAL DEADLINE TUESDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX (PR Newswire)
14.08.23	ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX (PR Newswire)
07.08.23	TOP RANKED ROSEN LAW FIRM Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX (PR Newswire)
01.08.23	ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX (PR Newswire)
23.07.23	IBRX SHAREHOLDER ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX (PR Newswire)
13.07.23	ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX (PR Newswire)
04.07.23	ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IBRX (PR Newswire)
02.06.22	Pre-market Movers: BCAN, IMMX, AI, IBRX, RPTX… (RTTNews)
15.02.22	Pre-market Movers: RESN, LRMR, TSEM, IPW, SBEV… (RTTNews)
01.02.22	ImmunityBio: 'Kick & Kill' HIV Cure Strategy To Reduce HIV Viral Load With Anktiva Therapy; Stock Up (RTTNews)
03.01.22	AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE (PR Newswire)
08.11.21	Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine (PR Newswire)
17.05.21	ImmunityBio Gets FDA Authorisation For Phase 1 Human Study Of NK Cell Platform With IL-15 Anktiva (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V